Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5077002 | 0.95 | DNM1 (0.31) | DNM1 | |
| SCHEMBL1736138 | 0.92 | DNM1 (0.38) | DNM1KCNH2RECQLGLAHPGD | |
| SCHEMBL1735953 | 0.86 | DNM1 (0.32) | DNM1KCNH2 | |
| SCHEMBL1735074 | 0.86 | DNM1 (0.40) | DNM1KCNH2RECQLGLAHPGD | |
| SCHEMBL5597592 | 0.83 | DNM1 (0.30) | DNM1 | |
| SCHEMBL357971 | 0.80 | DNM1 (0.34) | DNM1KCNH2 | |
| Potassium Ion SCHEMBL2196769 | 0.80 | — | — | |
| SCHEMBL358748 | 0.77 | DNM1 (0.50) | DNM1KCNH2RECQLGLAHPGD | |
| SCHEMBL358624 | 0.76 | DNM1 (0.44) | DNM1KCNH2RECQLGLAHPGD | |
| Trifluoromethanesulfonic Acid SCHEMBL2761030 | 0.75 | DNM1 (0.54) | DNM1KCNH2RECQLGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070100181-A1 | Olefin isomerization | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-03 | — | — | US | claimed |
| US-20070100184-A1 | Alkylation of aromatic compounds | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070100184-A1 | Alkylation of aromatic compounds | TYR, ALK, AHR | DNM1 3341/4885KCNH2 1186/4885RECQL 4177/4885 |
| US-20070100181-A1 | Olefin isomerization | OSBP, OXER1, ALOX12 | DNM1 607/4885KCNH2 2857/4885RECQL 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.